Deal Announcements

FlowCardia Secures $30 Million Series C Funding

Tuesday, September 04, 2007 5:00:00 AM PDT | VentureDeal Staff

SUNNYVALE, CA -- Medical device company FlowCardia, Inc. has received a third round of financing, receiving $30 million from a large syndicate of venture capital firms.

FlowCardia designs and develops technologies to enable the crossing of totally occluded coronary and peripheral arteries.  The company's focus is on the treatment of Chronic Total Occlusions.

Investors in the round were lead Glide Healthcare Partners, and included Life Sciences Partners, Pappas Ventures, Frazier Healthcare Ventures, H&Q, New Science Ventures, Rockport Capital Partners, Gold Hill Capital and JPMorgan Partners.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1